We still use the CDM in its standard form and extend where we need to. So all of the OHDSI tools would still work. We’ve only used Achilles at the local OMOPs, we’ve never been able to get it to finish running on the central version. Can you point me to the Data Quality Dashboard?
Hello. My name is William Johns and I am the CEO of National Provider Network based in Hawthorne, NY. NPN and our affiliated companies provide EHR and RCM systems and supporting services to medical providers in the US. We have an extensive and growing medical dataset derived from millions of patient records, claims, and transcriptions. We are currently working on our CDM mapping. Prior to this, I enjoyed a long career on Wall Street. Having seen some action on the front lines of the medical information world, I have developed views on the potential to improve our understanding of patient information and to use that knowledge. We are looking forward to working with OHDSI.
My interests include AIML in healthcare, EHR/RCM system design, predictive analytics, patient identification, public policy, and entrepreneurship.
Hello! My name is Abi Mawer and I have a BSc in Biomedical science and an MSc in international development. I have worked for the last few years across different aspects of RWD in healthcare and am keen to work more with open access data. I am interesting in patient pathway mapping across the EU and investigating data sets to support these. I have worked mostly with UK data sets so am interested to hear what is available across the globe.
Hello everyone. I’m Maria Tereza Fernandes Abrahao. By way of introduction, I am a health scientist and have been working for over 25 years in the area of systems and database development.
I have a doctorate from the University of São Paulo Medical School, In my doctoral project, I developed a common data model and performed clinical data analysis for a cardiovascular disease referral hospital in Sao Paulo. I used free software tools and performed data analysis in R. My work was contemporary with the development of OHDSI, and I have been following the community ever since.
I am currently committed to education and publicity for OHDSI in Brazil. I would like to know how I can promote OHDSI and the tools in a participatory way with the community. I would like to start an OHDSI Brazil participatory group.
Some links to know my work:
short course: https://sol.sbc.org.br/livros/index.php/sbc/catalog/download/29/94/244-1?inline=1
Hello, my name is Pablo J. Madril, who graduated as an Electronics Engineer from the University of Buenos Aires, living in São Paulo, Brazil since 1985. I’m a software developer and want to help to promote OHDSI in Brazil and also to develop for it. I am making available a JSON Schema for Atlas Cohort Definition at Github as a way to spread the use of cohort definitions outside OHDSI. Hope somebody finds it useful, feedback is welcomed.
Hello, I am Sanish Davis a CR Professional working with J&J in India and also the General Secretary of Indian Society for Clinical Research (ISCR). ISCR was Launched in June 2005 as a professional association of all stakeholder groups involved in Clinical Research. It is a registered society with a charter to represent interests of the Clinical Research community. It’s mission is to Inspire and align diverse stakeholders to shape and foster an environment facilitating ethical and responsible clinical research for better patient outcomes. ISCR members belong to diverse groups - Institutions/Companies involved in Clinical Research (AMOs),Individual members from the Clinical Research industry,Investigators and site staff,Members of Ethics Committees,Others interested and trained in Clinical Research. ISCR works through councils and chapters. we have 7 councils and 3 chapters (e.g. Investigator, training, regulatory, zonal chapters etc.). The newest council is Real World Evidence (RWE) council. I am working as the RWE council coordinator till formal elections occur and I would like to check if OHDSI would like to partner with ISCR as a platform for RWE in India. This will be mutually beneficial for both the organizations. ISCR will gain through knowledge philanthropy from OHSDI and OHSDI will be able to grow in this important area of the world.
My name is Ken Cottrell; I’ve been on your forum email list for several months but this is the first time I’ve introduced myself. I have done some independent contract work with Common Data Model on Postgres, to integrate this with clinical trial repositories.
Currently I am doing some research to implement CDM healthcare code terminology mapping on an in-memory, distributed database. I’m hoping to use the Apache Ignite database (https://ignite.apache.org/) to improve the throughput for terminology mapping and code crosswalk processes for payers and providers. I look forward to hearing more from all of you.
Hi, I am David. I have worked in multiple domains in health care including, patient care, clinical research operations, research ethics (IRB world as a Scientific IRB member and IRB Board Manager in the US), and currently, in pharmacovigilance. I would love to collaborate with someone looking for a medical review of their data for research purposes. I am interested in expanding my skills in both patient- and population level data analysis.
A great way to get started in the community is to join our weekly community calls which take place every Tuesday at 12pm ET. If you’d like to join today’s meeting, the details to join are here: OHDSI Community Call - 12Nov2019
Thank you Maura! I need to adjust my schedule to make this call, but look forward to joining it in the near future
Hi, I’m Ruth Etzioni from Fred Hutch Cancer Center in Seattle and the Knight Cancer Institute in Portland. I am a statistician and population scientist focusing on cancer research. I grew up in South Africa where a confluence of events led me to study statistics, eventually graduating with a statistics PhD from Carnegie-Mellon University. In my research I use statistical and simulation models to address evidence gaps that inevitably arise in medical decision making and cancer policy development. As an PI of the Cancer Intervention and Surveillance Network I focus mainly on prostate cancer but I also have projects in breast cancer and melanoma. I also teach a course on organic statistics for large public healthcare databases to graduate students in the school of public health at the University of Washington (what is “organic statistics?” please free free to ask! I am a strong believer in the value of community and a culture of generosity. I look forward to learning more about OHDSI and developing some great collaborative projects in cancer population sciences.